Shigeto Kawai

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

Masahiko Mihara, Keiko Kasutani, Makoto Okazaki et al. · International Immunopharmacology · 2005 · 318 citations

Inflammation, Il-6 Cytokine Family, Cytokine +14

Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells

Toshihiko Ohtomo, Yasuhiro Sugamata, Yasuko Ozaki et al. · Biochemical and Biophysical Research Communications · 1999 · 199 citations

Histocompatibility, Immunology, Antigen Processing +6

Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target

Hirotaka Ito, S. Funahashi, Naoko Yamauchi et al. · Clinical Cancer Research · 2006 · 99 citations

The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity

Koichiro Ono, Toshihiko Ohtomo, Kenji Yoshida et al. · Molecular Immunology · 1999 · 40 citations

Humanized Anti-hm1.24 Antibody, Hematological Malignancy, Malignant Blood Disorder +6

Interferon‐α enhances CD317 expression and the antitumor activity of anti‐CD317 monoclonal antibody in renal cell carcinoma xenograft models

Shigeto Kawai, Yumiko Azuma, Etsuko Fujii et al. · Cancer Science · 2008 · 40 citations · Full text

Cd317 Expression, Antitumor Activity, Cancer Immunosurveillance +14